JPS5780314A - Pharmaceutical preparation to be medicated to rectum - Google Patents

Pharmaceutical preparation to be medicated to rectum

Info

Publication number
JPS5780314A
JPS5780314A JP55157169A JP15716980A JPS5780314A JP S5780314 A JPS5780314 A JP S5780314A JP 55157169 A JP55157169 A JP 55157169A JP 15716980 A JP15716980 A JP 15716980A JP S5780314 A JPS5780314 A JP S5780314A
Authority
JP
Japan
Prior art keywords
acid
rectum
pharmaceutical preparation
main drug
medicated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP55157169A
Other languages
Japanese (ja)
Inventor
Kazuhiko Kitao
Kenichi Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto Pharmaceutical Industries Ltd
Original Assignee
Kyoto Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharmaceutical Industries Ltd filed Critical Kyoto Pharmaceutical Industries Ltd
Priority to JP55157169A priority Critical patent/JPS5780314A/en
Publication of JPS5780314A publication Critical patent/JPS5780314A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To pharmacutical preparation to be medicated to the rectum having improved rectum absorption of a main drug, obtained by blending a pharmaceutical preparation comprising an aminoglycoside type antibiotic and/or polysaccharide as the main drug with specific amount of a 8W14C farty acid, leucic acid, and/or their nontoxic salts.
CONSTITUTION: A pharmaceutical preparation to be medicated to the rectum comprising 0.5W2wt% based on total pharmaceutical preparation of carboxylic acids selected from the group consisting of 8W14C fatty acid (preferably capric acid, lauric acid), leucic acid, their nontoxic salts, e.g., alkali metal salt, basic amino acid salt, etc. and a main drug selected from the group consisting of an aminoglycoside type antibiotic, e.g., gentamycin, etc., a polysaccharide, e.g., heparin, etc., a peptide having a molecular weight of ≤4,000, e.g., ACTH, etc., a mercaptoproline derivative, and a nucleic acid type compound, e.g., citicoline, etc., wherein the main drug can be absorbed from the rectum to the blood extremely easily.
COPYRIGHT: (C)1982,JPO&Japio
JP55157169A 1980-11-09 1980-11-09 Pharmaceutical preparation to be medicated to rectum Pending JPS5780314A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55157169A JPS5780314A (en) 1980-11-09 1980-11-09 Pharmaceutical preparation to be medicated to rectum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55157169A JPS5780314A (en) 1980-11-09 1980-11-09 Pharmaceutical preparation to be medicated to rectum

Publications (1)

Publication Number Publication Date
JPS5780314A true JPS5780314A (en) 1982-05-19

Family

ID=15643689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55157169A Pending JPS5780314A (en) 1980-11-09 1980-11-09 Pharmaceutical preparation to be medicated to rectum

Country Status (1)

Country Link
JP (1) JPS5780314A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
EP0418582A2 (en) * 1989-08-31 1991-03-27 E.R. SQUIBB & SONS, INC. Method for treating hypermotility diseases of the bowel employing an ace inhibitor
US6887906B1 (en) * 1997-07-01 2005-05-03 Isispharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54160713A (en) * 1978-06-05 1979-12-19 Kali Chemie Pharma Gmbh Medical preparation with improved absorbability and production
JPS5857407A (en) * 1981-09-30 1983-04-05 Toa Nenryo Kogyo Kk Catalytic component for olefin polymerization

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54160713A (en) * 1978-06-05 1979-12-19 Kali Chemie Pharma Gmbh Medical preparation with improved absorbability and production
JPS5857407A (en) * 1981-09-30 1983-04-05 Toa Nenryo Kogyo Kk Catalytic component for olefin polymerization

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
EP0418582A2 (en) * 1989-08-31 1991-03-27 E.R. SQUIBB & SONS, INC. Method for treating hypermotility diseases of the bowel employing an ace inhibitor
US6887906B1 (en) * 1997-07-01 2005-05-03 Isispharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal

Similar Documents

Publication Publication Date Title
CA1161362A (en) Pharmaceutical compositions containing a corticosteroid substance
FR2596393B1 (en) HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
RU97107611A (en) DRUGS OF ALPHA-INTERFERON IN THE FORM OF STABLE AQUEOUS SOLUTION
BG60261B2 (en) Lon-acting formulation of cefaclor
RU2002106399A (en) MOXIFLOXACIN COMPOSITIONS CONTAINING SODIUM SALT
SE8402551D0 (en) CINNAMOYLMORANOLIN DERIVATIVES
ZA894828B (en) Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base,with elimination,in solution,of the bitter taste,burning of the throat and intestinal toxicity
ZA82149B (en) Carboxylic acid derivatives, their preparation and use as pharmaceutical compositions
KR900014406A (en) Cefem compound and preparation method thereof
JPS5780314A (en) Pharmaceutical preparation to be medicated to rectum
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
BE885605A (en) BENZO (IJ) QUINOLIZINE-CARBOXYLIC-2 ACID DERIVATIVES USEFUL IN PARTICULAR AS ANTIMICROBIAL DRUGS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS AND PHARMACEUTICAL FORMS CONTAINING THEM
AU689603B2 (en) A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
JPS56138110A (en) Suppository containing citric acid or salt thereof
ES8305001A1 (en) Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them.
JPS57146722A (en) Pharmaceutical preparation having improved absorption
JPS57146723A (en) Pharmaceutical preparation having improved absorption
CA1336491C (en) Antiviral pharmaceutical composition
US4391809A (en) Methods for treating psoriasis
KR890009868A (en) Trometamine salt of 1-methyl-β-oxo-α- (phenylcarbamoyl) -2-pyrrolepropionitrile
IE34648L (en) Pharmaceutical composition containing garcinia acid
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
IE810396L (en) SALTS OF 4'-(9-ACRIDINYLAMINO)-METHANESULPHONE-m-ANISIDIDE
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
ES8505383A1 (en) Pharmaceutical compositions with antibiotic-immunostimulating activity.